$100m-$499m
Cleerly captures investors’ hearts in $192m series C
Launched just a year ago to build on work at Weill Cornell Medicine and New York-Presbyterian Hospital, Cleerly has now closed an oversubscribed series C round.
ReCode registers $120m series B extension
UT Southwestern Medical Center spinout ReCode Therapeutics has now raised a total of $200m in its series B round from investors including Osage University Partners.
Zap Energy zips to $160m series C
University of Washington spinout Zap Energy is working on building a cheap, scalable fusion reactor generating low cost and carbon free energy.
Finn finds way to $110m series B
UVC Partners has taken part in the round, which will allow Finn to expand further across the US while bolstering its market position in Europe.
Aurion Biotech advances with $120m
Exploiting research conducted at Kyoto Prefecture University of Medicine, Aurion Biotech is focusing on therapies that can restore vision.
Improbable imports $150m in funding
The metaverse technology developer has now pushed its overall funding past $750m since emerging out of Cambridge’s Department of Computer Science and Technology.
Retro looks ahead with $180m
The company, which largely remains in stealth mode, has set itself a mission of increasing the human lifespan by a decade.
Source Global captures $150m
Relying on Arizona State University research, Source Global has developed panels that generate clean drinking water from sunlight and water vapour.
Other News
Affini-T discovers $175m
The co-founders of Fred Hutch's oncology therapeutics developer include Philip Greenberg who previously helped launch Juno Therapeutics.
Jeeves serves up $180m series C
The corporate card provider was valued at $2.1bn in a round backed by Stanford University that increased its funding to $380m altogether.
Triumvira steers series A up to $100m
Triumvera, co-founded by McMaster's professor Jonathan Bramson, looks to progress its solid tumour therapeutic candidate.
SiFive secures $175m series F
UC Berkeley spinout SiFive has fetched a $2.5bn valuation in a series F round that pushed its overall financing to more than $350m.
Scipher Medicine unlocks $110m round
Cowen Healthcare Investments has led a funding round for Scipher Medicine, co-founded by Harvard Medical School colleagues Joseph Loscalzo and Albert-László Barabási.
MindMaze finds way to $105m
EPFL spinout MindMaze has raised $105m from investors including AlbaCore Capital, which had supplied $125m in capital only four months ago.
Editor's Picks
The Standout Six: The deals you need to know about this week
Healthcare companies may be driving a public markets recovery while Lunar Energy, helmed by Tesla's former head of energy, has emerged from stealth with $300m.
SoftBank co-leads $200m CoachHub series C
The digital coaching app developer pushed its overall funding past $330m in a series C round co-led by SoftBank Vision Fund 2.
SoftBank chips into Bucketplace’s $182m round
The owner of home renovation platform Today’s House (Ohouse)’s latest round helped value it at $1.4bn and push its total funding to $261m.
Porsche leads Group14’s $400m series C
Automaker Porsche has led the SK Materials, Amperex, Showa Denko Cabot and BASF-backed EV battery technology provider’s fresh round to help advance the EV industry.
About us
Global University Venturing (GUV) is where tech transfer, academic and investment experts meet to explore the latest ideas and technologies driving innovation forward. We drive the discussions and share best practices that are critical to the success of spinouts, scaleouts and innovation programmes. Our aim is to help improve the processes of bringing innovations from academia to global markets and facilitate their integration into the broader business ecosystem.
Navigation
